{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,10]],"date-time":"2024-07-10T04:24:26Z","timestamp":1720585466363},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"The Queen Elizabeth Hospital Research Foundation","award":["200904"],"award-info":[{"award-number":["200904"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vascular Pharmacology"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1016\/j.vph.2014.11.003","type":"journal-article","created":{"date-parts":[[2014,11,20]],"date-time":"2014-11-20T21:17:26Z","timestamp":1416518246000},"page":"17-22","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Post receptor determinants of acute platelet response to clopidogrel in patients with symptomatic myocardial ischemia"],"prefix":"10.1016","volume":"65-66","author":[{"given":"V.B.","family":"Nooney","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.L.","family":"Hurst","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.Y.","family":"Chirkov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"De Caterina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.D.","family":"Horowitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vph.2014.11.003_bb0005","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S0140-6736(01)05701-4","article-title":"Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study","volume":"358","author":"Mehta","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.vph.2014.11.003_bb0010","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1056\/NEJMoa010746","article-title":"Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation","volume":"345","author":"Yusuf","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vph.2014.11.003_bb0015","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1046\/j.1365-2796.2002.01027.x","article-title":"Individual variations of platelet inhibition after loading doses of clopidogrel","volume":"252","author":"J\u00e4remo","year":"2002","journal-title":"J Intern Med"},{"key":"10.1016\/j.vph.2014.11.003_bb0020","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1055\/s-0037-1613462","article-title":"Prevalence of clopidogrel non-responders among patients with stable angina pectoris scheduled for elective coronary stent placement","volume":"89","author":"M\u00fcller","year":"2003","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.vph.2014.11.003_bb0025","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.thromres.2004.07.007","article-title":"Identification of low responders to a 300-mg clopidogrel loading dose in patients undergoing coronary stenting","volume":"115","author":"Angiolillo","year":"2005","journal-title":"Thromb Res"},{"key":"10.1016\/j.vph.2014.11.003_bb0030","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.jacc.2006.10.050","article-title":"Increased risk in patients with high platelet aggregation receiving chronic clopidogrel therapy undergoing percutaneous coronary intervention. Is the current antiplatelet therapy adequate?","volume":"49","author":"Bliden","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.vph.2014.11.003_bb0035","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1080\/09537100802351065","article-title":"Platelet reactivity to adenosine diphosphate and long-term ischemic event occurrence following percutaneous coronary intervention: a potential antiplatelet therapeutic target","volume":"19","author":"Gurbel","year":"2008","journal-title":"Platelets"},{"key":"10.1016\/j.vph.2014.11.003_bb0040","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1056\/NEJMoa0809171","article-title":"Cytochrome P-450 polymorphisms and response to clopidogrel","volume":"360","author":"Mega","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vph.2014.11.003_bb0045","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1001\/jama.2010.1543","article-title":"Reduced-function CYP2C19 genotype and risk of adverse clinical outcomes among patients treated with clopidogrel predominantly for PCI: a meta-analysis","volume":"304","author":"Mega","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/j.vph.2014.11.003_bb0050","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/j.jacc.2012.11.040","volume":"61","author":"Frelinger","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.vph.2014.11.003_bb0055","doi-asserted-by":"crossref","first-page":"3171","DOI":"10.1161\/01.CIR.0000130846.46168.03","article-title":"Clopidogrel resistance is associated with increased risk of recurrent atherothrombotic events in patients with acute myocardial infarction","volume":"109","author":"Matetzky","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.vph.2014.11.003_bb0060","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/j.1538-7836.2007.02812.x","article-title":"The residual platelet aggregation after deployment of intracoronary stent (PREDICT) score","volume":"6","author":"Geisler","year":"2008","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.vph.2014.11.003_bb0065","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1016\/j.amjcard.2009.07.015","article-title":"Relation of body mass index to high on-treatment platelet reactivity and of failed clopidogrel dose adjustment according to platelet reactivity monitoring in patients undergoing percutaneous coronary intervention","volume":"104","author":"Bonello-Palot","year":"2009","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.vph.2014.11.003_bb0070","first-page":"169","article-title":"Platelet aggregation according to body mass index in patients undergoing coronary stenting: should clopidogrel loading-dose be weight adjusted?","volume":"16","author":"Angiolillo","year":"2004","journal-title":"J Invasive Cardiol"},{"key":"10.1016\/j.vph.2014.11.003_bb0075","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.amjcard.2007.02.081","article-title":"Impact of body mass index on platelet aggregation after administration of a high loading dose of 600mg of clopidogrel before percutaneous coronary intervention","volume":"100","author":"Sibbing","year":"2007","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.vph.2014.11.003_bb0080","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1016\/j.jacc.2007.05.049","article-title":"Impact of platelet reactivity on cardiovascular outcomes in patients with type 2 diabetes mellitus and coronary artery disease","volume":"50","author":"Angiolillo","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.vph.2014.11.003_bb0085","doi-asserted-by":"crossref","first-page":"2430","DOI":"10.2337\/diabetes.54.8.2430","article-title":"Platelet function profiles in patients with type 2 diabetes and coronary artery disease on combined aspirin and clopidogrel treatment","volume":"54","author":"Angiolillo","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.vph.2014.11.003_bb0090","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.jacc.2010.09.032","article-title":"Cardiovascular mortality in chronic kidney disease patients undergoing percutaneous coronary intervention is mainly related to impaired P2Y12 inhibition by clopidogrel","volume":"57","author":"Morel","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.vph.2014.11.003_bb0095","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1093\/ndt\/gft027","article-title":"Impaired platelet P2Y12 inhibition by thienopyridines in chronic kidney disease: mechanisms, clinical relevance and pharmacological options","volume":"28","author":"Morel","year":"2013","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.vph.2014.11.003_bb0100","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.jacc.2008.04.045","article-title":"The association of cigarette smoking with enhanced platelet inhibition by clopidogrel","volume":"52","author":"Bliden","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.vph.2014.11.003_bb0105","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1001\/jama.2012.5930","article-title":"Clopidogrel efficacy and cigarette smoking status","volume":"307","author":"Gurbel","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.vph.2014.11.003_bb0110","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1016\/j.jacc.2006.11.044","article-title":"Variability in individual responsiveness to clopidogrel. Clinical implications, management, and future perspectives","volume":"49","author":"Angiolillo","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.vph.2014.11.003_bb0115","doi-asserted-by":"crossref","first-page":"20029","DOI":"10.1074\/jbc.273.32.20029","article-title":"Analysis and regulation of vasodilator-stimulated phosphoprotein serine 239 phosphorylation in vitro and in intact cells using a phosphospecific monoclonal antibody","volume":"273","author":"Smolenski","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1016\/j.vph.2014.11.003_bb0120","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1111\/j.1432-1033.1987.tb13357.x","article-title":"Vasodilator-stimulated protein phosphorylation in platelets is mediated by cAMP- and cGMP-dependent protein kinases","volume":"167","author":"Waldmann","year":"1987","journal-title":"Eur J Biochem"},{"key":"10.1016\/j.vph.2014.11.003_bb0125","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1093\/emboj\/18.1.37","article-title":"The vasodilator-stimulated phosphoprotein (VASP) is involved in cGMP- and cAMP-mediated inhibition of agonist-induced platelet aggregation, but is dispensable for smooth muscle function","volume":"18","author":"Aszodi","year":"1999","journal-title":"EMBO J"},{"key":"10.1016\/j.vph.2014.11.003_bb0130","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.vph.2013.10.002","article-title":"Clopidogrel \u201cresistance\u201d: pre- vs post-receptor determinants","volume":"59","author":"Hurst","year":"2013","journal-title":"Vascul Pharmacol"},{"key":"10.1016\/j.vph.2014.11.003_bb0135","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0143-4160(03)00170-2","article-title":"Inhibition of ADP-induced intracellular Ca2+ responses and platelet aggregation by the P2Y12 receptor antagonists AR-C69931MX and clopidogrel is enhanced by prostaglandin E1","volume":"35","author":"Fox","year":"2004","journal-title":"Cell Calcium"},{"key":"10.1016\/j.vph.2014.11.003_bb0140","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1111\/j.1538-7836.2007.02356.x","article-title":"Inhibition of the platelet P2Y12 receptor for adenosine diphosphate potentiates the antiplatelet effect of prostacyclin","volume":"5","author":"Cattaneo","year":"2007","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.vph.2014.11.003_bb0145","doi-asserted-by":"crossref","first-page":"504","DOI":"10.3109\/09537104.2011.576284","article-title":"P2Y12 and EP3 antagonists promote the inhibitory effects of natural modulators of platelet aggregation that act via cAMP","volume":"22","author":"Iy\u00fa","year":"2011","journal-title":"Platelets"},{"key":"10.1016\/j.vph.2014.11.003_bb0150","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1007\/BF00168445","article-title":"Suppressed anti-aggregating and cGMP-elevating effects of sodium nitroprusside in platelets from patients with stable angina pectoris","volume":"354","author":"Chirkov","year":"1996","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"10.1016\/j.vph.2014.11.003_bb0155","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1161\/01.CIR.100.2.129","article-title":"Nitrate resistance in platelets from patients with stable angina pectoris","volume":"100","author":"Chirkov","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.vph.2014.11.003_bb0160","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1097\/00005344-199506000-00015","article-title":"Impaired responsiveness of platelets from patients with stable angina pectoris to antiaggregating and cyclic AMP-elevating effects of prostaglandin E1","volume":"25","author":"Chirkov","year":"1995","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.vph.2014.11.003_bb0165","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/j.1538-7836.2004.01063.x","article-title":"Flow cytometric analysis of intraplatelet VASP phosphorylation for the detection of clopidogrel resistance in patients with ischemic cardiovascular diseases","volume":"3","author":"Aleil","year":"2005","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.vph.2014.11.003_bb0170","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1161\/CIRCULATIONAHA.109.885194","article-title":"Cytochrome 2C19*17 allelic variant, platelet aggregation, bleeding events, and stent thrombosis in clopidogrel-treated patients with coronary stent placement","volume":"121","author":"Sibbing","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.vph.2014.11.003_bb0175","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.jacc.2008.11.030","article-title":"Platelet reactivity after clopidogrel treatment assessed with point-of-care analysis and early drug-eluting stent thrombosis","volume":"53","author":"Sibbing","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.vph.2014.11.003_bb0180","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1001\/jama.2009.1232","article-title":"Association of cytochrome P450 2C19 genotype with the antiplatelet effect and clinical efficacy of clopidogrel therapy","volume":"302","author":"Shuldiner","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.vph.2014.11.003_bb0185","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1001\/jama.2011.1332","article-title":"High residual platelet reactivity after clopidogrel loading and long-term cardiovascular events among patients with acute coronary syndromes undergoing PCI","volume":"306","author":"Parodi","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.vph.2014.11.003_bb0190","first-page":"1","article-title":"Inhibition by ADP of prostaglandin induced accumulation of cyclic AMP in intact human platelets","volume":"7","author":"Macfarlane","year":"1981","journal-title":"J Cyclic Nucleotide Res"},{"key":"10.1016\/j.vph.2014.11.003_bb0195","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1177\/1358836X9800300312","article-title":"Clinical pharmacology of the adenosine diphosphate (ADP) receptor antagonist, clopidogrel","volume":"3","author":"Schr\u00f6r","year":"1998","journal-title":"Vasc Med"},{"key":"10.1016\/j.vph.2014.11.003_bb0200","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/282517a0","article-title":"ADP is a potent inhibitor of human platelet plasma membrane adenylate cyclase","volume":"282","author":"Cooper","year":"1979","journal-title":"Nature"},{"key":"10.1016\/j.vph.2014.11.003_bb0205","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/S0140-6736(81)91733-5","article-title":"Differential inhibition by low-dose aspirin of human venous prostacyclin synthesis and platelet thromboxane synthesis","volume":"317","author":"Hanley","year":"1981","journal-title":"Lancet"},{"key":"10.1016\/j.vph.2014.11.003_bb0210","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1161\/01.CIR.84.2.679","article-title":"Suppression of eicosanoid biosynthesis during coronary angioplasty by fish oil and aspirin","volume":"84","author":"Braden","year":"1991","journal-title":"Circulation"},{"key":"10.1016\/j.vph.2014.11.003_bb0215","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1160\/TH08-08-0544","article-title":"Identifying clopidogrel resistance during chronic therapy: the case for a biochemical approach","volume":"100","author":"Horowitz","year":"2008","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.vph.2014.11.003_bb0220","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1111\/j.1538-7836.2011.04576.x","article-title":"Novel roles of cAMP\/cGMP\u2010dependent signaling in platelets","volume":"10","author":"Smolenski","year":"2012","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.vph.2014.11.003_bb0225","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1055\/s-0037-1615861","article-title":"Cyclic nucleotides and phosphodiesterases in platelets","volume":"82","author":"Haslam","year":"1999","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.vph.2014.11.003_bb0230","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1111\/j.1538-7836.2009.03733.x","article-title":"Which platelet function test is suitable to monitor clopidogrel responsiveness? A pharmacokinetic analysis on the active metabolite of clopidogrel","volume":"8","author":"Bouman","year":"2010","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.vph.2014.11.003_bb0235","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.thromres.2010.03.008","article-title":"The cone-and-plate(let) analyzer is not suitable to monitor clopidogrel therapy: a comparison with the flow cytometric VASP assay and optical aggregometry","volume":"126","author":"Van Werkum","year":"2010","journal-title":"Thromb Res"},{"key":"10.1016\/j.vph.2014.11.003_bb0240","doi-asserted-by":"crossref","first-page":"15782","DOI":"10.1073\/pnas.1218880110","article-title":"Blockade of the purinergic P2Y12 receptor greatly increases the platelet inhibitory actions of nitric oxide","volume":"110","author":"Kirkby","year":"2013","journal-title":"Proc Natl Acad Sci"}],"container-title":["Vascular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1537189114001918?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1537189114001918?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,17]],"date-time":"2019-08-17T12:58:11Z","timestamp":1566046691000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1537189114001918"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2]]},"references-count":48,"alternative-id":["S1537189114001918"],"URL":"https:\/\/doi.org\/10.1016\/j.vph.2014.11.003","relation":{},"ISSN":["1537-1891"],"issn-type":[{"value":"1537-1891","type":"print"}],"subject":[],"published":{"date-parts":[[2015,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Post receptor determinants of acute platelet response to clopidogrel in patients with symptomatic myocardial ischemia","name":"articletitle","label":"Article Title"},{"value":"Vascular Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vph.2014.11.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}